Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Theurich

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
JMIR Cancer|February 12, 2026
Scan, Screen, Support - A Digital Pathway to Assess Supportive Care Needs in Oncology: An Implementation StudyTheres Fey, Nicole Thurner, Ulrike Haidn, et al.
JMIR Cancer|March 19, 2026
Scan, Screen, Support-A Digital Pathway for Assessing Supportive Care Needs in Oncology: Implementation StudyTheres Fey, Nicole Thurner, Ulrike Haidn, et al.
Seminars in Oncology Nursing|January 11, 2025
Nutrition Care in Cancer: An Overlooked Part of Patient-Centered CareNicole Erickson, Virpi Sulosaari, Erin Stella Sullivan, et al.
BMC Cancer|August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial dataMartin Kortüm, Sebastian Theurich, James Farrell, et al.
Frontiers in Pharmacology|June 4, 2019
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Pharmacology|February 22, 2020
Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Blood|August 6, 2005
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myelomaThorsten Stühmer, Manik Chatterjee, Martin Hildebrandt, et al.
Nature Immunology|March 3, 2015
NK cells link obesity-induced adipose stress to inflammation and insulin resistanceFelix M Wensveen, Vedrana Jelenčić, Sonja Valentić, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
JMIR Cancer|February 12, 2026
Scan, Screen, Support - A Digital Pathway to Assess Supportive Care Needs in Oncology: An Implementation StudyTheres Fey, Nicole Thurner, Ulrike Haidn, et al.
JMIR Cancer|March 19, 2026
Scan, Screen, Support-A Digital Pathway for Assessing Supportive Care Needs in Oncology: Implementation StudyTheres Fey, Nicole Thurner, Ulrike Haidn, et al.
Seminars in Oncology Nursing|January 11, 2025
Nutrition Care in Cancer: An Overlooked Part of Patient-Centered CareNicole Erickson, Virpi Sulosaari, Erin Stella Sullivan, et al.
BMC Cancer|August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial dataMartin Kortüm, Sebastian Theurich, James Farrell, et al.
Frontiers in Pharmacology|June 4, 2019
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Pharmacology|February 22, 2020
Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer, Sin Yuin Yeo, Thorsten Persigehl, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Blood|August 6, 2005
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myelomaThorsten Stühmer, Manik Chatterjee, Martin Hildebrandt, et al.
Nature Immunology|March 3, 2015
NK cells link obesity-induced adipose stress to inflammation and insulin resistanceFelix M Wensveen, Vedrana Jelenčić, Sonja Valentić, et al.
Pageof 15